0001127602-12-002987.txt : 20120130
0001127602-12-002987.hdr.sgml : 20120130
20120130164125
ACCESSION NUMBER: 0001127602-12-002987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120126
FILED AS OF DATE: 20120130
DATE AS OF CHANGE: 20120130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAGEMANN ROBERT
CENTRAL INDEX KEY: 0001222676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 12556096
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2012-01-26
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222676
HAGEMANN ROBERT
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
SVP & Chief Financial Officer
Common Stock
2012-01-26
4
M
0
113334
52.235
A
253009
D
Common Stock
2012-01-26
4
S
0
100604
59.0918
D
152405
D
Common Stock
2012-01-26
4
S
0
12730
59.6543
D
139675
D
Common Stock
1772
I
SDCP
Stock Options (Right to Buy)
52.235
2012-01-26
4
M
0
113334
0
D
2013-02-15
Common Stock
113334
0
D
The options vested in three annual installments with the first on February 15, 2007, the second on February 15, 2008 and the final on February 15, 2009.
This transaction was executed in multiple trades at prices ranging from $58.60 to $59.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $59.60 to $59.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes exempt purchases made under the Company's stock purchase plan.
These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann
2012-01-30